medical decision support medical decision support
Sign In

Binding-Stimulation Index (BSI) of Tamaki et al for Evaluating a Newborn for Overt Thyrotoxicosis

Description

Some neonates born to mothers with Graves's disease will develop overt thyrotoxicosis while others will not. Tamaki et al developed a binding-stimulation index to help identify neonates with overt thyrotoxicosis requiring therapy. The authors are from Osaka University in Japan.


 

Parameters:

(1) TSH binding inhibitor immunoglobulin (TBII), expressed in U/mL

(2) thyroid stimulating antibody (TSAb) expressed in TSH microunit equivalents (TSH µUEq)

 

Methods:

(1) TSH binding inhibitor immunoglobulin: radioreceptor assay from Travenol Co, with normal reference range < 0.5 U/mL

(2) thyroid stimulating antibody: increase in cycle AMP in FRL-5 cells compared to TSH, with normal reference range < 0.35 TSH µUEq

 

binding stimulation index =

= (TBII) * (TSAb)

 

Interpretation:

• minimum score: 0

• maximum score: > 200

• A score > 15 predicts neonatal overt thyrotoxicosis, even if the mother was treated with antithyroid medications.

 


To read more or access our algorithms and calculators, please log in or register.

Specialty

ICD-10